Previous Close | 17.87 |
Open | 17.89 |
Bid | 18.26 x 1000 |
Ask | 18.36 x 800 |
Day's Range | 18.02 - 18.34 |
52 Week Range | 17.10 - 20.65 |
Volume | |
Avg. Volume | 500,858 |
Market Cap | 1.858B |
Beta (5Y Monthly) | 1.37 |
PE Ratio (TTM) | 5.59 |
EPS (TTM) | 3.27 |
Earnings Date | Feb 23, 2022 - Feb 28, 2022 |
Forward Dividend & Yield | 1.80 (10.03%) |
Ex-Dividend Date | Jun 29, 2022 |
1y Target Est | 18.83 |
Investors need to pay close attention to The Goldman Sachs (GS) stock based on the movements in the options market lately.
(Bloomberg) -- Goldman Sachs Group Inc.’s private equity arm has agreed to buy a controlling stake in Norgine BV from the specialty pharmaceutical company’s founding Stein family.Most Read from BloombergRare Ship-to-Ship Transfers Keep Oil Moving From Russia to ChinaStocks See Widespread Rally Amid Retail Strength: Markets WrapThese Are the Best — and Worst — Cities for Work-Life BalanceTop Gun: Maverick's F-18 Flights Cost New Tom Cruise Film $11,374 an HourFed Saw Aggressive Hikes Providing Fl
Goldman Sachs (GS) closed the most recent trading day at $313.95, moving -0.84% from the previous trading session.